Literature DB >> 8792088

Pleiotrophin and midkine in normal development and tumor biology.

A Kurtz1, A M Schulte, A Wellstein.   

Abstract

Pleiotrophin (PTN) and midkine (MK) are members of a family of developmentally regulated, secreted heparin-binding proteins. The proteins are structural homologs, and are highly conserved among species. Although no homology has been detected with other heparin-binding growth factors, their functional similarity to members of the fibroblast growth factor (FGF) family is remarkable. PTN and MK are expressed during embryogenesis, showing an expression pattern that suggests functions in neurogenesis, cell migration, secondary organogenetic induction, and mesoderm-epithelial interaction. The widespread downregulation of PTN and MK in the adult human is reverted in a number of cancers, in which polypeptides are able to act as both transforming growth factors and promoters of angiogenesis. Elucidating the molecular mechanisms of PTN and MK action could lead not only to a deeper understanding of developmental processes, but also to the ultimate identification of targets for tumor therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8792088

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  15 in total

Review 1.  Pancreatic cancer.

Authors:  C Güngör; B T Hofmann; G Wolters-Eisfeld; M Bockhorn
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 2.  Embryonic reversions and lineage infidelities in tumour cells: genome-based models and role of genetic instability.

Authors:  Leon P Bignold
Journal:  Int J Exp Pathol       Date:  2005-04       Impact factor: 1.925

3.  Promotion of self-renewal of embryonic stem cells by midkine.

Authors:  Xing Yao; Zhou Tan; Bin Gu; Rong-rong Wu; Yu-kan Liu; Li-cheng Dai; Ming Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-05       Impact factor: 6.150

4.  Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury.

Authors:  H J Yeh; Y Y He; J Xu; C Y Hsu; T F Deuel
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

5.  Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus.

Authors:  A M Schulte; S Lai; A Kurtz; F Czubayko; A T Riegel; A Wellstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

6.  Solution structure of midkine, a new heparin-binding growth factor.

Authors:  W Iwasaki; K Nagata; H Hatanaka; T Inui; T Kimura; T Muramatsu; K Yoshida; M Tasumi; F Inagaki
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

7.  Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage.

Authors:  Hanayo Kawai; Waichi Sato; Yukio Yuzawa; Tomoki Kosugi; Seiichi Matsuo; Yoshifumi Takei; Kenji Kadomatsu; Takashi Muramatsu
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

8.  Expression and purification of bioactive high-purity human midkine in Escherichia coli.

Authors:  Zhong-hui Zhang; Li-juan Du; Di Xiang; Shun-ying Zhu; Ming-yuan Wu; Hui-li Lu; Yan Yu; Wei Han
Journal:  J Zhejiang Univ Sci B       Date:  2009-02       Impact factor: 3.066

9.  Pleiotrophin is a neurotrophic factor for spinal motor neurons.

Authors:  Ruifa Mi; Weiran Chen; Ahmet Höke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

Review 10.  Demystified. Human endogenous retroviruses.

Authors:  P N Nelson; P R Carnegie; J Martin; H Davari Ejtehadi; P Hooley; D Roden; S Rowland-Jones; P Warren; J Astley; P G Murray
Journal:  Mol Pathol       Date:  2003-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.